[Event Report] The Second Roundtable Discussion “Examining Numeric Targets for AMR Countermeasures – Setting Appropriate Performance Indicators in the Next AMR Action Plan” (June 30, 2021)
date : 8/16/2021
Tags: AMR
On June 30, 2021, AMR Alliance Japan held its second roundtable discussion on “Examining Numeric Targets for AMR Countermeasures – Setting Appropriate Performance Indicators in the Next AMR Action Plan”
It is estimated that as many as 8,000 people die every year in Japan of AMR-related causes, double the amount of people who die annually from traffic accidents. Globally, AMR leads to the death of up to 700,000 people annually. If trends continue, 10 million people could potentially die of AMR-related causes globally every year by 2050.
Japan’s “National Action Plan on Antimicrobial Resistance (AMR) 2016-2020” (hereafter “AMR Action Plan”) set six goals and numeric targets toward the achievement of the plan. While the numeric targets did help to promote AMR countermeasures, there is concern that they may have in some instances led to excessive disuse of antimicrobials, even in cases where antimicrobial use was appropriate.
The next AMR Action Plan for Japan has not been released as of June 2021. Toward the new plan, this meeting gathered expert opinion on how to set numerical targets for AMR countermeasures from FY2021 onward.
■Overview
Date: Wednesday, June 30, 2021
Format: Online (Zoom Meeting)
Host: AMR Alliance Japan (Secretariat: Health and Global Policy Institute)
■Program
Opening and Explanation of Purpose
Honda Akiko (Member of the House of Councillors)
Presentations
“Human Numerical Targets for the Next Action Plan”
Kazuhiro Tateda (President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
“Animal Numerical Targets for the Next Action Plan”
Tetsuo Asai (Professor, Joint Graduate School of Veterinary Sciences, Gifu University)
Round Table Discussion
Issues Related to Setting Numerical Targets in the Next Action Plan
Moderator:
Tomohito Shibata (Manager, Health and Global Policy Institute)
Top Research & Recommendations Posts
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)



